Hamilton Thorne (CVE:HTL) Stock Price Up 4.3% – Time to Buy?

Hamilton Thorne Ltd. (CVE:HTL – Get Free Report)’s stock price rose 4.3% on Tuesday. The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares changed hands during trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Up 4.3%

The stock has a market cap of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54. The company has a current ratio of 2.04, a quick ratio of 2.25 and a debt-to-equity ratio of 43.24. The stock’s 50-day moving average price is C$1.45 and its 200-day moving average price is C$1.45.

About Hamilton Thorne

(Get Free Report)

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.

Further Reading

• Five stocks we like better than Hamilton Thorne
• There’s a New Q in Town: Invesco’s ETF Targets International Innovators
• Boarding Now—GE Aerospace’s Earnings Beat Comes With a Catch
• AI Spending Is Surging—But Which Stocks Still Win if It Slows Down?
• Are RTX Corporation and Northrop Grumman Ready to Break Out?